News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
701,206 Results
Type
Article (41615)
Company Profile (463)
Press Release (659128)
Section
Business (208409)
Career Advice (2005)
Deals (35943)
Drug Delivery (92)
Drug Development (83308)
Employer Resources (169)
FDA (16325)
Job Trends (15046)
News (352106)
Policy (32979)
Tag
Academia (2619)
Alliances (50618)
Alzheimer's disease (1274)
Approvals (16252)
Artificial intelligence (139)
Bankruptcy (361)
Best Places to Work (11733)
Biotechnology (349)
Breast cancer (124)
Cancer (1120)
Cardiovascular disease (102)
Career advice (1673)
Cell therapy (250)
Clinical research (66010)
Collaboration (409)
Compensation (202)
COVID-19 (2591)
C-suite (100)
Data (1145)
Diabetes (156)
Diagnostics (6198)
Earnings (86048)
Employer resources (147)
Events (112943)
Executive appointments (316)
FDA (16874)
Funding (370)
Gene therapy (194)
GLP-1 (612)
Government (4410)
Healthcare (18996)
Infectious disease (2676)
Inflammatory bowel disease (113)
Interviews (308)
IPO (16574)
Job creations (3695)
Job search strategy (1429)
Layoffs (439)
Legal (7928)
Lung cancer (174)
Manufacturing (181)
Medical device (13322)
Medtech (13327)
Mergers & acquisitions (19433)
Metabolic disorders (426)
Neuroscience (1565)
NextGen Class of 2024 (6734)
Non-profit (4533)
Northern California (1500)
Obesity (245)
Opinion (198)
Patents (103)
People (57633)
Phase I (20689)
Phase II (29141)
Phase III (21547)
Pipeline (462)
Postmarket research (2590)
Preclinical (8888)
Radiopharmaceuticals (252)
Rare diseases (235)
Real estate (5998)
Regulatory (21961)
Research institute (2404)
Resumes & cover letters (351)
Southern California (1327)
Startups (3748)
United States (13902)
Vaccines (565)
Weight loss (183)
Date
Today (132)
Last 7 days (705)
Last 30 days (3808)
Last 365 days (36740)
2024 (33723)
2023 (41014)
2022 (52276)
2021 (56766)
2020 (54924)
2019 (47420)
2018 (35697)
2017 (33028)
2016 (32348)
2015 (38397)
2014 (32189)
2013 (27110)
2012 (29222)
2011 (29866)
2010 (27996)
Location
Africa (731)
Arizona (200)
Asia (38524)
Australia (6403)
California (3425)
Canada (1300)
China (254)
Colorado (150)
Connecticut (162)
Europe (84014)
Florida (464)
Georgia (116)
Illinois (354)
Indiana (199)
Kansas (99)
Maryland (590)
Massachusetts (2732)
Michigan (159)
Minnesota (279)
New Jersey (972)
New York (977)
North Carolina (759)
Northern California (1500)
Ohio (141)
Pennsylvania (853)
South America (1105)
Southern California (1327)
Texas (478)
Utah (92)
Washington State (375)
701,206 Results for "sirna therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Aphios Granted US Patent For siRNA Targeted Therapeutics for Treatment of HIV-1 and Other Diseases
Aphios Corporation announced today that it has been granted US Patent No. 11,981,174 for CCR5 and CD4 siRNA-targeted therapeutics for treatment of HIV-1 and other diseases.
May 15, 2024
·
2 min read
Press Releases
Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions
November 18, 2024
·
3 min read
Press Releases
Wave Life Sciences Highlights Growing Pipeline at Research Day, including INHBE siRNA Program for Obesity and New RNA Editing Programs
October 31, 2024
·
9 min read
Press Releases
Brii Bio Delivers First Head-to-Head Comparison of siRNA (Elebsiran) and PEG-IFNα Combination versus PEG-IFNα Alone at AASLD’s The Liver Meeting® 2024, Demonstrating Higher Loss of HBV Surface Antigen by Combining with siRNA
November 19, 2024
·
6 min read
Altamira Therapeutics Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation
Altamira Therapeutics Ltd. today announced that it has filed a provisional patent application with the United States Patent Office (USPTO) which covers nanoparticles comprising the Company’s OligoPhore™ platform and siRNA targeting the p65 protein, a component of the NF-κB transcription factor.
May 1, 2024
·
8 min read
Press Releases
Codexis Announces Three siRNA Manufacturing Data Presentations at TIDES Europe Annual Meeting
October 24, 2024
·
7 min read
Press Releases
siRNA Biotech Rigerna Bio Secured over USD$30m Initial Financing with Aspirations to Create Therapies for Kidney Patients
November 6, 2024
·
1 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
BioCapital
Innovent and SanegeneBio Enter Strategic Collaboration to Develop siRNA Drug for the Treatment of Hypertension
Innovent Biologics, Inc. and Sanegene Bio USA Inc. announce that they have entered into a collaboration agreement to co-develop SGB-3908, an siRNA drug candidate targeting angiotensinogen for the treatment of hypertension.
December 26, 2023
·
8 min read
Drug Development
Sirius Therapeutics Begins Phase 1 Clinical Trial of Next-Generation, Long-Acting Factor XI siRNA Anticoagulant for Treatment of Thromboembolic Disorders
Sirius Therapeutics, announced it has dosed the first subject in a Phase 1, first-in-human clinical trial in Australia of SRSD107 on January 30th 2024, its next generation siRNA therapeutic targeting coagulation Factor XI, for the prevention and treatment of thromboembolic disorders.
February 1, 2024
·
2 min read
1 of 70,121
Next
